JAML immunotherapy targets recently activated tumor-infiltrating CD8+ T cells.

Leave a Reply

Facebook Youtube Linkedin Instagram

contact@lji.org
9420 Athena Circle
La Jolla, CA 92037

Phone: +1 (858) 752-6500

© 2025 La Jolla Institute for Immunology. All rights reserved. LJI is a 501(c)(3) tax-exempt organization. Federal Tax ID Number 33-0328688